Kumar B Rajan1, Zoe Arvanitakis2, Elizabeth B Lynch2, Elizabeth A McAninch2, Robert S Wilson2, Jennifer Weuve2, Lisa L Barnes2, Antonio C Bianco2, Denis A Evans2. 1. From the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL. kumar_rajan@rush.edu. 2. From the Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer's Disease Center (Z.A., R.S.W., L.L.B.), Departments of Neurological Sciences (Z.A., R.S.W., L.L.B.) and Preventive Medicine (E.B.L.), and Division of Endocrinology and Metabolism (E.A.M., A.C.B.), Rush University Medical Center, Chicago, IL.
Abstract
OBJECTIVE: To examine if incident and preexisting diabetes mellitus (DM) were associated with cognitive decline among African Americans (AAs) and European Americans (EAs). METHODS: Based on a prospective study of 7,740 older adults (mean age 72.3 years, 64% AA, 63% female), DM was ascertained by hypoglycemic medication use and Medicare claims during physician or hospital visits, and cognition by performance on a brief battery for executive functioning, episodic memory, and Mini-Mental State Examination (MMSE). Decline in composite and individual tests among those with incident DM, with preexisting DM, and without DM was studied using a linear mixed effects model with and without change point. RESULTS: At baseline, 737 (15%) AAs and 269 (10%) EAs had preexisting DM. Another 721 (17%) AAs and 289 (12%) EAs had incident DM in old age. Following incident DM, cognitive decline increased by 36% among AAs and by 40% among EAs compared to those without DM. No significant difference was observed between AAs and EAs (p = 0.64). However, cognitive decline increased by 17% among AAs with preexisting DM compared to those without DM, but no increased decline was observed among EAs with preexisting DM. In secondary analyses, faster decline in executive functioning and episodic memory was observed following incident DM. CONCLUSIONS: In old age, faster cognitive decline was present among AAs and EAs following incident DM, compared to cognitive decline prior to DM, and among those without DM. This underscores the need for stronger prevention and control of DM in old age.
OBJECTIVE: To examine if incident and preexisting diabetes mellitus (DM) were associated with cognitive decline among African Americans (AAs) and European Americans (EAs). METHODS: Based on a prospective study of 7,740 older adults (mean age 72.3 years, 64% AA, 63% female), DM was ascertained by hypoglycemic medication use and Medicare claims during physician or hospital visits, and cognition by performance on a brief battery for executive functioning, episodic memory, and Mini-Mental State Examination (MMSE). Decline in composite and individual tests among those with incident DM, with preexisting DM, and without DM was studied using a linear mixed effects model with and without change point. RESULTS: At baseline, 737 (15%) AAs and 269 (10%) EAs had preexisting DM. Another 721 (17%) AAs and 289 (12%) EAs had incident DM in old age. Following incident DM, cognitive decline increased by 36% among AAs and by 40% among EAs compared to those without DM. No significant difference was observed between AAs and EAs (p = 0.64). However, cognitive decline increased by 17% among AAs with preexisting DM compared to those without DM, but no increased decline was observed among EAs with preexisting DM. In secondary analyses, faster decline in executive functioning and episodic memory was observed following incident DM. CONCLUSIONS: In old age, faster cognitive decline was present among AAs and EAs following incident DM, compared to cognitive decline prior to DM, and among those without DM. This underscores the need for stronger prevention and control of DM in old age.
Authors: Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks Journal: JAMA Date: 2003-01-01 Impact factor: 56.272
Authors: R S Wilson; D A Bennett; J L Bienias; N T Aggarwal; C F Mendes De Leon; M C Morris; J A Schneider; D A Evans Journal: Neurology Date: 2002-12-24 Impact factor: 9.910
Authors: Kimberly M Henderson; Cari J Clark; Tené T Lewis; Neelum T Aggarwal; Todd Beck; Hongfei Guo; Scott Lunos; Ann Brearley; Carlos F Mendes de Leon; Denis A Evans; Susan A Everson-Rose Journal: Stroke Date: 2012-12-13 Impact factor: 7.914
Authors: M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112
Authors: Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider Journal: Arch Neurol Date: 2003-02
Authors: Katherine J Bangen; Yian Gu; Alden L Gross; Brooke C Schneider; Jeannine C Skinner; Andreana Benitez; Bonnie C Sachs; Regina Shih; Shannon Sisco; Nicole Schupf; Richard Mayeux; Jennifer J Manly; José A Luchsinger Journal: J Am Geriatr Soc Date: 2015-06-11 Impact factor: 5.562
Authors: Sarah C Kelly; Erin C McKay; John S Beck; Timothy J Collier; Anne M Dorrance; Scott E Counts Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Lei Yu; Michael W Lutz; Jose M Farfel; Robert S Wilson; Daniel K Burns; Ann M Saunders; Philip L De Jager; Lisa L Barnes; Julie A Schneider; David A Bennett Journal: Alzheimers Dement Date: 2017-06-15 Impact factor: 21.566
Authors: John M Clements; Brady T West; Zachary Yaker; Breanna Lauinger; Deven McCullers; James Haubert; Mohammad Ali Tahboub; Gregory J Everett Journal: Diabetes Res Clin Pract Date: 2019-12-15 Impact factor: 5.602
Authors: Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao Journal: Alzheimers Dement Date: 2018-04-18 Impact factor: 21.566
Authors: Megan Zuelsdorff; Ozioma C Okonkwo; Derek Norton; Lisa L Barnes; Karen L Graham; Lindsay R Clark; Mary F Wyman; Susan F Benton; Alexander Gee; Nickolas Lambrou; Sterling C Johnson; Carey E Gleason Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472